RAB Versus Ultrathin Bronchoscopy With VBN in the Diagnosis of PPNs
ConditionPeripheral Pulmonary Nodules
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorShanghai Chest Hospital
About this trial
The purpose of this study is to evaluate whether the diagnostic yield of robotic-assisted bronchoscopy is not inferior to that of the virtual bronchoscopic navigation combined with ultrathin bronchoscopy.
Eligibility criteria
Qualifiers
Age ≥ 18 years, regardless of gender;
Patients with peripheral lung nodules of suspected malignancy on chest CT who require non-surgical biopsy;
Patients who voluntarily consent to undergo bronchoscopy and meet the requirements for the bronchoscopy;
Patients should understand the purpose of the trial, demonstrate good compliance with the examinations and follow-ups, and voluntarily participate in the clinical trial and sign the informed consent form.
Disqualifiers
Presence of contraindications for bronchoscopy, including: active massive hemoptysis; recent myocardial infarction or unstable angina; severe cardiac or pulmonary dysfunction; severe hypertension and arrhythmias; uncorrectable bleeding tendencies or severe coagulation disorders (such as platelet count <60×10^9/L), uremia; severe pulmonary artery hypertension; severe superior vena cava syndrome; intracranial hypertension; acute cerebrovascular events; aortic dissection or aneurysm; multiple bullae; extreme systemic exhaustion;
Patients with pure ground-glass nodules suspected of malignancy on chest CT;
Female patients who are breastfeeding, pregnant, or planning pregnancy;
Patients with electromagnetic active implantable medical devices;
Trial design
Treatments tested in this trial
- Robotic bronchoscopy system
- Ultrathin bronchoscope combined with virtual bronchoscopic navigation
Treatment groups
186 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov